BIOMAT Database Logo BIOMAT Database Logo

Therapeutic abortion following midtrimester amniocentesis. 1985

N J Leschot, and M Verjaal, and P E Treffers

UI MeSH Term Description Entries
D008297 Male Males
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011262 Pregnancy Trimester, Second The middle third of a human PREGNANCY, from the beginning of the 15th through the 28th completed week (99 to 196 days) of gestation. Midtrimester,Pregnancy, Second Trimester,Trimester, Second,Midtrimesters,Pregnancies, Second Trimester,Pregnancy Trimesters, Second,Second Pregnancy Trimester,Second Pregnancy Trimesters,Second Trimester,Second Trimester Pregnancies,Second Trimester Pregnancy,Second Trimesters,Trimesters, Second
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D005260 Female Females
D005817 Genetic Counseling An educational process that provides information and advice to individuals or families about a genetic condition that may affect them. The purpose is to help individuals make informed decisions about marriage, reproduction, and other health management issues based on information about the genetic disease, the available diagnostic tests, and management programs. Psychosocial support is usually offered. Counseling, Genetic,Genetic Counseling, Prenatal,Prenatal Genetic Counseling
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000032 Abortion, Therapeutic Abortion induced to save the life or health of a pregnant woman. (From Dorland, 28th ed) Therapeutic Abortion,Abortions, Therapeutic,Therapeutic Abortions
D000649 Amniocentesis Percutaneous transabdominal puncture of the uterus during pregnancy to obtain amniotic fluid. It is commonly used for fetal karyotype determination in order to diagnose abnormal fetal conditions. Amniocenteses
D012729 Sex Chromosome Aberrations Abnormal number or structure of the SEX CHROMOSOMES. Some sex chromosome aberrations are associated with SEX CHROMOSOME DISORDERS and SEX CHROMOSOME DISORDERS OF SEX DEVELOPMENT. Sex Chromosome Abnormalities,Abnormalities, Sex Chromosome,Chromosome Abnormalities, Sex,Aberration, Sex Chromosome,Aberrations, Sex Chromosome,Abnormality, Sex Chromosome,Chromosome Aberration, Sex,Chromosome Aberrations, Sex,Chromosome Abnormality, Sex,Sex Chromosome Aberration,Sex Chromosome Abnormality

Related Publications

N J Leschot, and M Verjaal, and P E Treffers
Spontaneous abortion after midtrimester amniocentesis.
February 1979, Obstetrics and gynecology,
N J Leschot, and M Verjaal, and P E Treffers
Transcervical amniocentesis - hypertonic saline instillation for midtrimester abortion.
January 1975, Advances in planned parenthood,
N J Leschot, and M Verjaal, and P E Treffers
Midtrimester amniocentesis.
April 1979, Obstetrics and gynecology,
N J Leschot, and M Verjaal, and P E Treffers
Numerous needle-mark injuries following midtrimester amniocentesis.
July 1998, Clinical dysmorphology,
N J Leschot, and M Verjaal, and P E Treffers
Parental response to mid-trimester therapeutic abortion following amniocentesis.
January 1984, Prenatal diagnosis,
N J Leschot, and M Verjaal, and P E Treffers
Midtrimester therapeutic abortion using intraamniotic PGF2alpha.
January 1973, Advances in the biosciences,
N J Leschot, and M Verjaal, and P E Treffers
Midtrimester abortion: clinical experience with amniocentesis and hypertonic instillation in 400 patients.
February 1971, Modern treatment,
N J Leschot, and M Verjaal, and P E Treffers
Midtrimester abortion: clinical experience with amniocentesis and hypertonic instillation in 400 patients.
March 1971, Clinical obstetrics and gynecology,
N J Leschot, and M Verjaal, and P E Treffers
Complications following prostaglandin F2alpha-induced midtrimester abortion.
September 1975, Obstetrics and gynecology,
N J Leschot, and M Verjaal, and P E Treffers
Midtrimester abortion.
January 1981, Obstetrics and gynecology annual,
Copied contents to your clipboard!